LL-37 (17-29) [R23K]
General Information
DCTPep ID DCTPep02874
Peptide Name LL-37 (17-29) [R23K]
Sequence FKRIVQKIKDFLR
Sequence Length 13
UniProt ID P49913
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
ACP Tumor active peptide
Activity Information
Cell Line | Disease | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|
A549 | Lung adenocarcinoma | IC50=145.1 μg/ml | MTT assay | 24 h | 1 |
Hemolytic Activity Human erythrocytes: Not active up to 500 µg/ml
Normal (non-cancerous) Cytotoxicity DLF lung fibroblasts: Not active up to 200 µg/ml
Target Not available
Affinity Not available
Mechanism Not available
Structure Information
PDB ID Not available
Predicted Structure DCTPep02874
(Please note that there is the predicted structure, predicted by AlphaFold)
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C80H135N23O17
Absent amino acids ACEGHMNPSTWY
Theoretical pI 11.10
Acidic residues 1
Basic residues 5
Polar residues 0
Molecular weight (Average) 1691.1
Molecular weight (Monoisotopic) 1690.04
Common amino acids K
Net charge 4
Instability index (II) 12.17
Aliphatic index 112.31
Grand average of hydropathicity (GRAVY) -0.392
Half Life
1.1 hours (mammalian reticulocytes, in vitro).
3 min (yeast, in vivo).
2 min (Escherichia coli, in vivo).
Extinction coefficients
Should not be visible by UV spectrophotometry.
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 32567085
Title Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the development of antimicrobial/anticancer agents
Doi 10.1002/psc.3254
Year 2020
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID DBAASPS_17792